The effect of anti-thyroid drug treatment duration on thyroid gland microvessel density and intraoperative blood loss in patients with Graves' disease

Surgery

Volumn 143, Issue 2, 2008, Pages 216-225

  Erbil, Yeşim ^a   Giriş, Murat ^b   Salmaslioglu, Artur ^b   Ozluk, Yasemin ^b   Barbaros, Umut ^a   Yanik, Burcu Tulumoǧlu ^a   Kapran, Yersu ^b   Abbasoglu, Semra Dogru ^b   Ozarmagan, Selcuk ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CD34 ANTIGEN; PROPRANOLOL; PROPYLTHIOURACIL; THIAMAZOLE;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; BLEEDING; CLINICAL ARTICLE; CORRELATION ANALYSIS; DOPPLER ECHOGRAPHY; FEMALE; GRAVES DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PEROPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TREATMENT DURATION; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTITHYROID AGENTS; BLOOD FLOW VELOCITY; BLOOD LOSS, SURGICAL; FEMALE; GRAVES DISEASE; HUMANS; MALE; METHIMAZOLE; MICROCIRCULATION; MIDDLE AGED; PREOPERATIVE CARE; PROPYLTHIOURACIL; REFERENCE VALUES; THYROID GLAND; THYROIDECTOMY; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 38649100633     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.07.036     Document Type: Article

References (21)

1. Weetman A.P. Graves' disease. N Engl J Med 343 (1995) 1236-1248
2. Cooper D.S. Hyperthyroidism. Lancet 362 (2003) 459-468
3. Abraham P., Avenell A., Park C.M., Watson W.A., and Bevan J.S. A systematic review of drug therapy for Graves' hyperthyroidism. Eur J Endocrinol 153 (2005) 489-498
4. Pearce E.N. Diagnosis and management of thyrotoxicosis. BMJ 332 (2006) 1369-1373
5. Thomusch O., Machens A., Sekulla C., Ukkat J., Lippert H., Gastinger I., et al. Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg 24 (2000) 1335-1341
6. Erbil Y., Barbaros U., Issever H., Borucu I., Salmaslioglu A., Mete O., et al. Predictive factors for recurrent laryngeal nerve palsy and hypoparathyroidism after thyroid surgery. Clin Otolaryngol 32 (2007) 32-37
7. Caruso G., Attard M., Caronia A., and Lagalla R. Color Doppler measurement of blood flow in the inferior thyroid artery in patients with autoimmune thyroid diseases. Eur J Radiol 36 (2000) 5-10
8. Fobbe F., Finche R., Reichenstein E., Schleusener H., and Wolf K.J. Appearance of thyroid disease using color coded duplex sonography. Eur J Radiol 9 (1989) 29-31
9. Ueda M., Inaba M., Kumeda Y., Nagasaki T., Hiura Y., Tahara H., et al. The significance of thyroid blood flow at the inferior thyroid artery as a predictor for early Graves' disease relapse. Clin Endocrinol 63 (2005) 657-662
10. Bogazzi F., Bartalena L., Brogioni S., Burelli A., Manetti L., Tanda M.L., et al. Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography. Eur J Endocrinol 140 (1999) 452-456
11. Summaria V., Salvatori M., Rufini V., Mirk P., Garganese M.C., and Romani M. Diagnostic imaging in thyrotoxicosis. Rays 24 (1999) 273-300
12. Ramsden J.D. Angiogenesis in the thyroid gland. J Endocrinol 166 (2000) 475-480
13. Turner H.E., Harris A.L., Melmed S., and Wass J.A. Angiogenesis in endocrine tumors. Endocr Rev 24 (2003) 600-632
14. Shabana W., Peeters E., Verbeek P., and Osteaux M.M. Reducing inter-observer variation in thyroid volume calculation using a new formula and technique. Eur J Ultrasound 16 (2003) 207-210
15. Veglio F., Frascisco M., Melchio R., Provera E., Rabbia F., Oliva S., et al. Assessment of renal resistance index after captopril test by Doppler in essential and renovascular hypertension. Kidney Int 48 (1995) 1611-1616
16. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1985) 76-85
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
18. Erbil Y., Ozluk Y., Giris M., Salmaslioglu A., Issever H., Barbaros U., et al. Effect of Lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease. J Clin Endocrinol Metab 92 (2007) 2182-2189
19. Ansaldo G.L., Pretolesi F., Varaldo E., Meola C., Minuto M., Borgonovo G., et al. Doppler evaluation of intrathyroid arterial resistances during preoperative treatment with Lugol's iodide solution in patients with diffuse toxic goiter. J Am Coll Surg 191 (2000) 607-612
20. Hodgson K.J., Lazarus J.H., Wheeler M.H., Woodcock J.P., Owen G.M., McGregor A.M., et al. Duplex scan-derived thyroid blood flow in euthyroid and hyperthyroid patients. World J Surg 12 (1988) 470-475
21. Huang S.M., Chow N.H., Lee H.L., and Wu T.J. The value of color flow Doppler ultrasonography of the superior thyroid artery in the surgical management of Graves disease. Arch Surg 138 (2003) 146-151